Migraleve Pink Film-Coated Tablets: SPC Guide
Quick summary: Migraleve Pink film-coated tablets are used for short-term relief of acute migraine symptoms. The product contains paracetamol, codeine phosphate and buclizine hydrochloride, and is intended to help with headache pain and associated...
This content is for educational purposes only and does not replace medical advice, diagnosis or treatment from a qualified healthcare professional.
Quick summary: Migraleve Pink film-coated tablets are used for short-term relief of acute migraine symptoms. The product contains paracetamol, codeine phosphate and buclizine hydrochloride, and is intended to help with headache pain and associated nausea.
Always check the patient leaflet or SPC for the latest directions, and speak to a pharmacist or doctor if you are unsure whether it is suitable for you.
Medical disclaimer: This article is for general information only and does not replace the official product information, a pharmacist’s advice, or a doctor’s assessment. Do not use this page to diagnose migraine or to decide on treatment changes.
What are Migraleve Pink film-coated tablets?
Migraleve Pink film-coated tablets are described in the source content as a medicine used for the short-term treatment of acute moderate pain, particularly migraine attacks. They are presented as a combination product that aims to relieve headache pain and help with nausea and vomiting that can occur during migraine.
The tablets are intended for limited use. The original content states they should not be used for more than three days without medical advice.
What do they contain?
According to the source content, each tablet contains:
- Paracetamol
- Codeine phosphate
- Buclizine hydrochloride
These ingredients are described as working together to address pain and migraine-associated nausea.
How to take Migraleve Pink
The original content gives the following general directions:
- Adults: 2 tablets at the first sign of a migraine attack.
- Repeat dose: if needed, wait at least 4 hours before taking more.
- Maximum: 8 tablets in 24 hours.
- Children aged 12 to 15 years: 1 tablet at the onset of a migraine.
Do not exceed the stated dose in the original content. If the leaflet you have differs, follow the official product information supplied with the medicine.
Important safety points
Because Migraleve Pink contains codeine, the source content highlights the need for caution with repeated use and the risk of dependence if used for too long. It also notes that the medicine should be used only for short-term migraine relief.
The content also warns that children under 12 should avoid this medicine because of the risks linked to opioid use.
Migraleve Pink vs Migraleve Yellow
The source content explains that Migraleve Pink and Migraleve Yellow are different formulations used in migraine treatment. It states that Migraleve Pink contains codeine, while Migraleve Yellow does not.
In the original article, Pink is described as the stronger option because of the codeine component, while Yellow is presented as a different formulation that may be used for less severe migraine attacks.
| Feature | Migraleve Pink | Migraleve Yellow |
|---|---|---|
| Codeine | Yes | No |
| Main use described in source | Migraine relief with nausea support | Different migraine formulation |
| Relative strength in source | Described as stronger | Described as less strong |
Risks in children
The source content specifically warns about use in children because of the codeine component. It notes the risk of serious side effects such as respiratory depression and the possibility of opioid dependence.
For this reason, the article states that children under 12 should avoid this medicine, and that medical guidance is important before use in younger patients.
What to check before use
If you are reading the official leaflet or SPC, it is sensible to confirm the following points with a pharmacist or doctor:
- whether the medicine is appropriate for your age group
- the correct dose and maximum daily amount
- how long it should be used for
- what to do if symptoms do not improve
- whether any other medicines you take may affect its use
These checks are especially important because the product contains codeine and is intended for short-term use only.
Frequently asked questions
▸ What is the pink tablet in Migraleve?
The pink tablet is the Migraleve formulation described in the source content as containing paracetamol, codeine phosphate and buclizine hydrochloride for migraine relief.
▸ Which is stronger, yellow or pink Migraleve?
The source content describes Migraleve Pink as stronger because it contains codeine, while Migraleve Yellow does not.
▸ How many pink Migraleve tablets can be taken in a day?
The original content states a maximum of 8 tablets in 24 hours for adults, with doses spaced at least 4 hours apart.
▸ Do pink Migraleve tablets make you drowsy?
The source content says drowsiness can occur, mainly because of the codeine component.
▸ Can children use Migraleve Pink?
The source content advises caution in children and says children under 12 should avoid it because of the risks linked to codeine.
Safety reminder
If migraine symptoms are severe, unusual, or keep returning, seek advice from a healthcare professional. Do not rely on this page for diagnosis, and do not change how you use the medicine without checking the official leaflet or speaking to a pharmacist or doctor.
Remember: the safest source for exact directions is the product’s official patient leaflet or SPC.
Medical disclaimer
This content is for educational purposes only. It should not be used as a substitute for professional medical advice, diagnosis or treatment. Always ask a doctor, pharmacist or qualified healthcare professional before starting, stopping or changing any medicine.
Sources and verification
The following sources or official references are listed to support verification of the medicine information discussed in this article.
- Electronic Medicines Compendium (emc) – Migraleve Pink SPC
- NHS – Migraine overview
- NHS – Codeine: medicine information
- NHS – Paracetamol for adults
- BNF (British National Formulary)
To improve this article with specific references, add a custom field named _aio_sources in the post editor and write one source per line using: Source title|Source URL.
Medicine information can change and may vary depending on country, product formulation, patient history and professional guidance. Always check official medicine information and ask a healthcare professional for personal medical questions.